246 filings
Page 2 of 13
8-K
ugimhrer
14 Sep 23
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
8:00am
8-K
x9ftxne8ml7v01
13 Sep 23
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
8:03am
424B8
rkrj15szrg9lg07l4
11 Sep 23
Prospectus unintentially filed late
4:41pm
8-K
tlhhzb
11 Sep 23
Nemaura Medical Completes 100 Patient Study for sugarBEATÒ 24-hour Wear and Reports Interim Results
9:00am
DEFA14A
w2yyni plymd
8 Sep 23
Additional proxy soliciting materials
4:30pm
8-K
sah90sopmk7boph8zpo5
17 Aug 23
Regulation FD Disclosure
8:30am
8-K
qwo5lny3d61
14 Aug 23
Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
8:30am
8-K
6rxpedt
11 Aug 23
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
5:07pm
PRE 14A
q550wnwnc
10 Aug 23
Preliminary proxy
4:05pm
EFFECT
mzqhx7zua mlx
8 Aug 23
Notice of effectiveness
12:15am
POS AM
0jod152bz
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
8-K
urj 7qlrfchk4bvyasq
14 Jul 23
Results of Operations and Financial Condition
9:18am
NT 10-K
gjtjj r1g8
29 Jun 23
Notice of late annual filing
6:05am
8-K
kai5vj6 gpd886lt3t
27 Jun 23
Nemaura Medical Scales-Up Pilot Expansion of proBEATTM; 56 Corporations in the USA signed up for pilots, in June 2023
9:00am
8-K
yfnjwogsvt85vg5
31 May 23
Changes in Registrant's Certifying Accountant
4:05pm
424B4
p21i9jvw8brrc5t
15 May 23
Prospectus supplement with pricing info
4:31pm